Two Sigma Advisers’s TRACON Pharmaceuticals TCON Stock Holding History
Bought
Maintained
Sold
Other funds holding TCON
OM
Two Sigma Advisers's TCON Position: Q2 2023 in Review
Two Sigma Advisers sold out of TRACON Pharmaceuticals (TCON) in Q2 2023, closing a stake of 515 shares — an estimated $19.5K sold.
Two Sigma Advisers first reported a position in TCON in Q1 2020 and held it in 12 quarters. The position peaked at $2.97M in Q4 2020. 27 funds tracked by Wall St. Rank hold TCON as of Q2 2023.
- Two Sigma Advisers reported no remaining TRACON Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
- Two Sigma Advisers sold 515 TRACON Pharmaceuticals shares in Q2 2023, an estimated $19.5K.
- Two Sigma Advisers first reported a position in TRACON Pharmaceuticals in Q1 2020 and held it in 12 quarters.
- Two Sigma Advisers's TRACON Pharmaceuticals position peaked at $2.97M in Q4 2020.
- 27 funds tracked by Wall St. Rank held TRACON Pharmaceuticals as of Q2 2023.
Based on Two Sigma Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.